Cargando…
A systematic review and meta-analysis of the efficacy and safety of arbidol in the treatment of coronavirus disease 2019
BACKGROUND: Coronavirus disease 2019 (COVID-19) is highly contagious, and the epidemic has spread to hundreds of countries around the world, and seriously threatens the life safety of people around the world. Arbidol is an antiviral drug with high potential against COVID-19, but evidence of effectiv...
Autores principales: | Wang, Xuemei, Xie, Ping, Sun, Guojuan, Zhao, Min, Deng, Zhumei, Zhou, Yunxia, Bao, Shuting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386950/ https://www.ncbi.nlm.nih.gov/pubmed/32791753 http://dx.doi.org/10.1097/MD.0000000000021402 |
Ejemplares similares
-
A systematic review and meta-analysis of the efficacy and safety of western medicine routine treatment combined with Chinese herbal medicine in the treatment of COVID-19
por: Wang, Xuemei, et al.
Publicado: (2020) -
Arbidol combined with the Chinese medicine Lianhuaqingwen capsule versus arbidol alone in the treatment of COVID-19
por: Liu, Lei, et al.
Publicado: (2021) -
Efficacy and safety of Shufeng Jiedu capsule for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis
por: Li, Runmin, et al.
Publicado: (2020) -
The efficacy of colchicine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysis
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2020) -
The effect of coagulation factors in 2019 novel coronavirus patients: A systematic review and meta-analysis
por: Xiang, Guiling, et al.
Publicado: (2021)